ask="4.00"
ask_size="1000"
average_daily_volume="3063870"
bid="3.95"
bid_size="3000"
book_value="-1.75"
change="-0.08"
change_from_200_day_moving_average="-1.37"
change_from_50_day_moving_average="-1.34"
change_from_52_week_high="-5.02"
change_From_52_week_low="0.10"
change_in_percent="-1.96%"
close="4.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.24"
ex_dividend_date="N/A"
float_shares="122562000"
high="4.11"
high_52_weeks="9.02"
last_trade_date="1/3/2017"
last_trade_price="4.00"
last_trade_size="100"
last_trade_time="4:00pm"
low="3.90"
low_52_weeks="3.90"
market_capitalization="518.46M"
moving_average_200_day="5.37"
moving_average_50_day="5.34"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.67"
open="4.10"
pe_ratio="N/A"
peg_ratio="-0.63"
percent_change_from_200_day_moving_average="-25.51%"
percent_change_from_50_day_moving_average="-25.16%"
percent_change_from_52_week_high="-55.63%"
percent_change_from_52_week_low="+2.56%"
previous_close="4.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="5.06"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="17.94"
stock_exchange="NGM"
symbol="MACK"
volume="3556615"
weeks_range_52="3.90 - 9.02"
